Centogene has announced that the company has recieved US Food and Drug Administration (FDA) approval for the issuance of Emergency Use Authorization (EUA) for its proprietary SARS-CoV-2 RT-PCR test called the CentoSure. The EUA allows the administration of the test for individuals who are not suffering from any COVID-19 symptoms, and to accelerate testing worldwide.
OraSure Technologies has announced that its DNA Genotek subsidiary received EUA for the use of its OMNIgene® oral saliva collection device. The at-home test kit is the first FDA approved device that can be collected and safely used by individuals at home and without the presence of any healthcare professional or in a healthcare setting.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Thermo Fisher Scientific has announced that it has received authorisation for the expansion of its EUA for the TaqPath COVID-19 Combo Kit, along with a home sample collection kit by Everlywell, a digital health testing company. The combined kit allows individuals to collect nasal swabs samples when instructed by a healthcare provider and after receiving the results of a COVID-19 questionnaire.
Beroni Group has collaborated with GenScript Biotech Corporation for the successful completion of a SARS-CoV-2 pseudovirus neutralisation assay. The assay helps fight the virus by targeting Covid-specific nanobodies and testing their affinity and efficacy, to try an prevent future infections.
